Gordon Winston Kinder - 25 Feb 2022 Form 4 Insider Report for Bluejay Diagnostics, Inc. (BJDX)

Role
Chief Financial Officer
Signature
/s/ Gordon Kinder
Issuer symbol
BJDX
Transactions as of
25 Feb 2022
Net transactions value
$0
Form type
4
Filing time
28 Feb 2022, 18:50:37 UTC
Previous filing
09 Nov 2021
Next filing
16 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BJDX Option to purchase common stock Award +8,066 +20% 48,066 25 Feb 2022 Common Stock 8,066 $1.09 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options set forth in this table vest in three equal annual installments, subject to the grantee's continued service to the Company on each vesting date.
F2 The stock options were issued in connection with the reporting person's employment services to the Company pursuant to the employment agreement between the reporting person and the Company dated July 1, 2021.